Global Custom Synthesis and Radiolabeling Market Outlook and Growth Opportunities 2026
Description
The global Custom Synthesis and Radiolabeling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Custom Synthesis and Radiolabeling market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Custom Synthesis and Radiolabeling market include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Custom Synthesis and Radiolabeling market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom Synthesis and Radiolabeling and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Synthesis and Radiolabeling revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Synthesis and Radiolabeling market.
Custom Synthesis and Radiolabeling Segment by Company
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology
Custom Synthesis and Radiolabeling Segment by Type
C-14
H-3
I-125
Others
Custom Synthesis and Radiolabeling Segment by Application
Drug Discovery
Medical
Others
Custom Synthesis and Radiolabeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Synthesis and Radiolabeling status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Synthesis and Radiolabeling key companies, revenue, market share, and recent developments.
3. To split the Custom Synthesis and Radiolabeling breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Synthesis and Radiolabeling market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Synthesis and Radiolabeling significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Synthesis and Radiolabeling competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Synthesis and Radiolabeling industry.
Chapter 3: Detailed analysis of Custom Synthesis and Radiolabeling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Synthesis and Radiolabeling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Synthesis and Radiolabeling in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
The North America market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Custom Synthesis and Radiolabeling market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Custom Synthesis and Radiolabeling market include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Custom Synthesis and Radiolabeling market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom Synthesis and Radiolabeling and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Synthesis and Radiolabeling revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Synthesis and Radiolabeling market.
Custom Synthesis and Radiolabeling Segment by Company
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology
Custom Synthesis and Radiolabeling Segment by Type
C-14
H-3
I-125
Others
Custom Synthesis and Radiolabeling Segment by Application
Drug Discovery
Medical
Others
Custom Synthesis and Radiolabeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Synthesis and Radiolabeling status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Synthesis and Radiolabeling key companies, revenue, market share, and recent developments.
3. To split the Custom Synthesis and Radiolabeling breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Synthesis and Radiolabeling market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Synthesis and Radiolabeling significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Synthesis and Radiolabeling competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Synthesis and Radiolabeling industry.
Chapter 3: Detailed analysis of Custom Synthesis and Radiolabeling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Synthesis and Radiolabeling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Synthesis and Radiolabeling in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
218 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Custom Synthesis and Radiolabeling Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Custom Synthesis and Radiolabeling Market Dynamics
- 2.1 Custom Synthesis and Radiolabeling Industry Trends
- 2.2 Custom Synthesis and Radiolabeling Industry Drivers
- 2.3 Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
- 2.4 Custom Synthesis and Radiolabeling Industry Restraints
- 3 Custom Synthesis and Radiolabeling Market by Company
- 3.1 Global Custom Synthesis and Radiolabeling Company Revenue Ranking in 2025
- 3.2 Global Custom Synthesis and Radiolabeling Revenue by Company (2021-2026)
- 3.3 Global Custom Synthesis and Radiolabeling Company Ranking (2024-2026)
- 3.4 Global Custom Synthesis and Radiolabeling Company Manufacturing Base and Headquarters
- 3.5 Global Custom Synthesis and Radiolabeling Company Product Type and Application
- 3.6 Global Custom Synthesis and Radiolabeling Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Custom Synthesis and Radiolabeling Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Custom Synthesis and Radiolabeling Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Custom Synthesis and Radiolabeling Market by Type
- 4.1 Custom Synthesis and Radiolabeling Type Introduction
- 4.1.1 C-14
- 4.1.2 H-3
- 4.1.3 I-125
- 4.1.4 Others
- 4.2 Global Custom Synthesis and Radiolabeling Sales Value by Type
- 4.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Type (2021-2032)
- 4.2.3 Global Custom Synthesis and Radiolabeling Sales Value Share by Type (2021-2032)
- 5 Custom Synthesis and Radiolabeling Market by Application
- 5.1 Custom Synthesis and Radiolabeling Application Introduction
- 5.1.1 Drug Discovery
- 5.1.2 Medical
- 5.1.3 Others
- 5.2 Global Custom Synthesis and Radiolabeling Sales Value by Application
- 5.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Application (2021-2032)
- 5.2.3 Global Custom Synthesis and Radiolabeling Sales Value Share by Application (2021-2032)
- 6 Custom Synthesis and Radiolabeling Regional Value Analysis
- 6.1 Global Custom Synthesis and Radiolabeling Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Custom Synthesis and Radiolabeling Sales Value by Region (2021-2032)
- 6.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Region: 2021-2026
- 6.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Custom Synthesis and Radiolabeling Sales Value (2021-2032)
- 6.3.2 North America Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Custom Synthesis and Radiolabeling Sales Value (2021-2032)
- 6.4.2 Europe Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Custom Synthesis and Radiolabeling Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Custom Synthesis and Radiolabeling Sales Value (2021-2032)
- 6.6.2 South America Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Custom Synthesis and Radiolabeling Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
- 7 Custom Synthesis and Radiolabeling Country-level Value Analysis
- 7.1 Global Custom Synthesis and Radiolabeling Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Custom Synthesis and Radiolabeling Sales Value by Country (2021-2032)
- 7.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Country (2021-2026)
- 7.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.7.2 France Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.14.2 China Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.17.2 India Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
- 8 Company Profiles
- 8.1 Charles River
- 8.1.1 Charles River Company Information
- 8.1.2 Charles River Business Overview
- 8.1.3 Charles River Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River Custom Synthesis and Radiolabeling Product Portfolio
- 8.1.5 Charles River Recent Developments
- 8.2 Eurofins Scientific
- 8.2.1 Eurofins Scientific Company Information
- 8.2.2 Eurofins Scientific Business Overview
- 8.2.3 Eurofins Scientific Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.2.4 Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
- 8.2.5 Eurofins Scientific Recent Developments
- 8.3 PerkinElmer
- 8.3.1 PerkinElmer Company Information
- 8.3.2 PerkinElmer Business Overview
- 8.3.3 PerkinElmer Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.3.4 PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
- 8.3.5 PerkinElmer Recent Developments
- 8.4 Sekisui Medical
- 8.4.1 Sekisui Medical Company Information
- 8.4.2 Sekisui Medical Business Overview
- 8.4.3 Sekisui Medical Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.4.4 Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
- 8.4.5 Sekisui Medical Recent Developments
- 8.5 Eckert & Ziegler
- 8.5.1 Eckert & Ziegler Company Information
- 8.5.2 Eckert & Ziegler Business Overview
- 8.5.3 Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.5.4 Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
- 8.5.5 Eckert & Ziegler Recent Developments
- 8.6 Labcorp
- 8.6.1 Labcorp Company Information
- 8.6.2 Labcorp Business Overview
- 8.6.3 Labcorp Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.6.4 Labcorp Custom Synthesis and Radiolabeling Product Portfolio
- 8.6.5 Labcorp Recent Developments
- 8.7 XenoTech (BioIVT)
- 8.7.1 XenoTech (BioIVT) Company Information
- 8.7.2 XenoTech (BioIVT) Business Overview
- 8.7.3 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.7.4 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
- 8.7.5 XenoTech (BioIVT) Recent Developments
- 8.8 Quotient Sciences
- 8.8.1 Quotient Sciences Company Information
- 8.8.2 Quotient Sciences Business Overview
- 8.8.3 Quotient Sciences Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.8.4 Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
- 8.8.5 Quotient Sciences Recent Developments
- 8.9 Gifford Bioscience
- 8.9.1 Gifford Bioscience Company Information
- 8.9.2 Gifford Bioscience Business Overview
- 8.9.3 Gifford Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.9.4 Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 8.9.5 Gifford Bioscience Recent Developments
- 8.10 ITM Radiopharma
- 8.10.1 ITM Radiopharma Company Information
- 8.10.2 ITM Radiopharma Business Overview
- 8.10.3 ITM Radiopharma Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.10.4 ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
- 8.10.5 ITM Radiopharma Recent Developments
- 8.11 Almac Group
- 8.11.1 Almac Group Company Information
- 8.11.2 Almac Group Business Overview
- 8.11.3 Almac Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.11.4 Almac Group Custom Synthesis and Radiolabeling Product Portfolio
- 8.11.5 Almac Group Recent Developments
- 8.12 Accelera
- 8.12.1 Accelera Company Information
- 8.12.2 Accelera Business Overview
- 8.12.3 Accelera Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.12.4 Accelera Custom Synthesis and Radiolabeling Product Portfolio
- 8.12.5 Accelera Recent Developments
- 8.13 Novandi Chemistry
- 8.13.1 Novandi Chemistry Company Information
- 8.13.2 Novandi Chemistry Business Overview
- 8.13.3 Novandi Chemistry Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.13.4 Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
- 8.13.5 Novandi Chemistry Recent Developments
- 8.14 AptoChem
- 8.14.1 AptoChem Company Information
- 8.14.2 AptoChem Business Overview
- 8.14.3 AptoChem Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.14.4 AptoChem Custom Synthesis and Radiolabeling Product Portfolio
- 8.14.5 AptoChem Recent Developments
- 8.15 HMR
- 8.15.1 HMR Company Information
- 8.15.2 HMR Business Overview
- 8.15.3 HMR Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.15.4 HMR Custom Synthesis and Radiolabeling Product Portfolio
- 8.15.5 HMR Recent Developments
- 8.16 AM Chemicals
- 8.16.1 AM Chemicals Company Information
- 8.16.2 AM Chemicals Business Overview
- 8.16.3 AM Chemicals Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.16.4 AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
- 8.16.5 AM Chemicals Recent Developments
- 8.17 PolyPeptide Group
- 8.17.1 PolyPeptide Group Company Information
- 8.17.2 PolyPeptide Group Business Overview
- 8.17.3 PolyPeptide Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.17.4 PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
- 8.17.5 PolyPeptide Group Recent Developments
- 8.18 NovoPro Bioscience
- 8.18.1 NovoPro Bioscience Company Information
- 8.18.2 NovoPro Bioscience Business Overview
- 8.18.3 NovoPro Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.18.4 NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 8.18.5 NovoPro Bioscience Recent Developments
- 8.19 Institute of Isotopes
- 8.19.1 Institute of Isotopes Company Information
- 8.19.2 Institute of Isotopes Business Overview
- 8.19.3 Institute of Isotopes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.19.4 Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
- 8.19.5 Institute of Isotopes Recent Developments
- 8.20 Nuvisan
- 8.20.1 Nuvisan Company Information
- 8.20.2 Nuvisan Business Overview
- 8.20.3 Nuvisan Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.20.4 Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
- 8.20.5 Nuvisan Recent Developments
- 8.21 Revvity
- 8.21.1 Revvity Company Information
- 8.21.2 Revvity Business Overview
- 8.21.3 Revvity Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.21.4 Revvity Custom Synthesis and Radiolabeling Product Portfolio
- 8.21.5 Revvity Recent Developments
- 8.22 Necsa
- 8.22.1 Necsa Company Information
- 8.22.2 Necsa Business Overview
- 8.22.3 Necsa Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.22.4 Necsa Custom Synthesis and Radiolabeling Product Portfolio
- 8.22.5 Necsa Recent Developments
- 8.23 Fluorizon
- 8.23.1 Fluorizon Company Information
- 8.23.2 Fluorizon Business Overview
- 8.23.3 Fluorizon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.23.4 Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
- 8.23.5 Fluorizon Recent Developments
- 8.24 Edinburgh Pharmaceutical Processes
- 8.24.1 Edinburgh Pharmaceutical Processes Company Information
- 8.24.2 Edinburgh Pharmaceutical Processes Business Overview
- 8.24.3 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.24.4 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
- 8.24.5 Edinburgh Pharmaceutical Processes Recent Developments
- 8.25 Chelatec
- 8.25.1 Chelatec Company Information
- 8.25.2 Chelatec Business Overview
- 8.25.3 Chelatec Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.25.4 Chelatec Custom Synthesis and Radiolabeling Product Portfolio
- 8.25.5 Chelatec Recent Developments
- 8.26 Pharmaron
- 8.26.1 Pharmaron Company Information
- 8.26.2 Pharmaron Business Overview
- 8.26.3 Pharmaron Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.26.4 Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
- 8.26.5 Pharmaron Recent Developments
- 8.27 Medicilon
- 8.27.1 Medicilon Company Information
- 8.27.2 Medicilon Business Overview
- 8.27.3 Medicilon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.27.4 Medicilon Custom Synthesis and Radiolabeling Product Portfolio
- 8.27.5 Medicilon Recent Developments
- 8.28 JOINN Laboratories
- 8.28.1 JOINN Laboratories Company Information
- 8.28.2 JOINN Laboratories Business Overview
- 8.28.3 JOINN Laboratories Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.28.4 JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
- 8.28.5 JOINN Laboratories Recent Developments
- 8.29 Frontage
- 8.29.1 Frontage Company Information
- 8.29.2 Frontage Business Overview
- 8.29.3 Frontage Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.29.4 Frontage Custom Synthesis and Radiolabeling Product Portfolio
- 8.29.5 Frontage Recent Developments
- 8.30 Abace Biotechnology
- 8.30.1 Abace Biotechnology Company Information
- 8.30.2 Abace Biotechnology Business Overview
- 8.30.3 Abace Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.30.4 Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 8.30.5 Abace Biotechnology Recent Developments
- 8.31 Beijing Atom High-Tech
- 8.31.1 Beijing Atom High-Tech Company Information
- 8.31.2 Beijing Atom High-Tech Business Overview
- 8.31.3 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.31.4 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
- 8.31.5 Beijing Atom High-Tech Recent Developments
- 8.32 Wuxi Beita Pharmatech
- 8.32.1 Wuxi Beita Pharmatech Company Information
- 8.32.2 Wuxi Beita Pharmatech Business Overview
- 8.32.3 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.32.4 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
- 8.32.5 Wuxi Beita Pharmatech Recent Developments
- 8.33 Beijing North Institute of Biotechnology
- 8.33.1 Beijing North Institute of Biotechnology Company Information
- 8.33.2 Beijing North Institute of Biotechnology Business Overview
- 8.33.3 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 8.33.4 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 8.33.5 Beijing North Institute of Biotechnology Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

